Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing for a broader set of tariffs that President ...

Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...

Apellis' Empaveli receives FDA Priority Review for rare kidney diseases C3G and IC-MPGN. Phase 3 data show strong efficacy in proteinuria reduction.

BioReference Health, a biotech company, is laying off 81 employees at its main laboratory in Elmwood Park. The move comes ...

Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved by the US Food and Drug ...

Workshops are a collaborative initiative led by Excelsus Structural Solutions (Switzerland), Purdue University, Argonne National Laboratory, and Improved Pharma (USA). These workshops serve as a ...